Company News: Johnson & Johnson and Basilea Pharmaceutica AG
The FDA told Johnson & Johnson that additional clinical studies are required before the agency will consider approving antibiotic ceftobiprole.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.